This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
ADSTILADRIN
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
ECLIPSE
ESCAPE
FORT
NRG-GU 0101
Masofaniten (EPI-7386)
METANOVA
RTIRE
SHORTER
Right Side
PCCTC
DORA
IRONMAN
PROMISE
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SESAUA 2024
Southern CA GU Cancer Research Forum 2024
AUA Urology Advocacy Summit 2024
ASCO GU 2024
2024 UCSF-UCLA PSMA Conference
SUO 2023
All Conferences
View All
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Conferences
Recent Abstracts
AUA 2016: Biomarkers of Abiraterone/Enzalutamide Resistance and Therapeutic Implications - Session Highlights
May 7, 2016
AUA 2016: Mechanisms of Castration-Resistance - Session Highlights
May 7, 2016
AUA 2016: Contemporary utilization trends of systemic chemotherapy for Upper Tract Urothelial Carcinoma (UTUC) - Poster Session Highlights
May 7, 2016
AUA 2016: Appropriateness Criteria for Active Surveillance for Prostate Cancer from the Michigan Urologic Surgery Improvement Collaborative - Session Highlights
May 7, 2016
AUA 2016: Increased Utilization of Multiparametic Magnetic Resonance Imaging for Detection and Management of Prostate Cancer - Session Highlights
May 7, 2016
AUA 2016: Variation in the Technical Skill of Surgeons Performing Robot-Assisted Radical Prostatectomy - Session Highlights
May 7, 2016
AUA 2016: Shared Discussion or Self-Promotion? Use of Twitter by U.S. Urology Residency Programs - Session Highlights
May 7, 2016
AUA 2016: Optimizing Patient Selection for Cytoreductive Nephrectomy in the Targeted Therapy Era - Session Highlights
May 7, 2016
AUA 2016: Reporting Standards of Indeterminate Renal Masses on CT and MRI: A National Survey of Urologists and Radiologists by the Society of Abdominal Radiology RCC Disease-Focused Panel - Session Highlights
May 7, 2016
AUA 2016: Automated Stone Volume Measurement Using Reduced-Dose (RD) CT Is Comparable Standard-Dose (SD) CT - Session Highlights
May 7, 2016
AUA 2016: Moderate chronic kidney disease (eGFR n bladder cancer patients treated with transurethral resection - Session Highlights
May 7, 2016
AUA 2016: The Significance of Anterior Prostate Lesions on Multiparametric MRI In African American Men - Session Highlights
May 7, 2016
AUA 2016: Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study - Session Highlights
May 7, 2016
AUA 2016: Validation of 3-D Volumetric Based Renal Function Prediction Calculator for Nephron Sparing Surgery - Session Highlights
May 7, 2016
AUA 2016: Comorbidity status as a predictor of high-grade status as a predictor of high-grade disease in men with prostate cancer - Session Highlights
May 7, 2016
AUA 2016: Pathophysiological relationship between pelvic organ prolapse and overactive bladder - Session Highlights
May 7, 2016
AUA 2016: Predictors of Genitourinary Malignancy Among Patients with Primary Microscopic Hematuria - Session Highlights
May 7, 2016
AUA 2016: Assessing the relative contribution of hospital and surgeon volume on short term mortality outcomes following radical cystectomy - Session Highlights
May 7, 2016
AUA 2016: Long-term outcomes of abdominal vs. vaginal apical prolapse repair among female Medicare beneficiaries - Session Highlights
May 7, 2016
AUA 2016: New Strategies for Infection Control: Insights from Evolutionary Ecology - Session Highlights
May 6, 2016
Page 462 of 548
Start
Prev
457
458
459
460
461
462
463
464
465
466
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free